nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—ORM1—Saquinavir—acquired immunodeficiency syndrome	0.0889	0.138	CbGbCtD
Maprotiline—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0347	0.0538	CbGbCtD
Maprotiline—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0327	0.0506	CbGbCtD
Maprotiline—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0327	0.0506	CbGbCtD
Maprotiline—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0295	0.0457	CbGbCtD
Maprotiline—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0286	0.0443	CbGbCtD
Maprotiline—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0286	0.0442	CbGbCtD
Maprotiline—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0269	0.0417	CbGbCtD
Maprotiline—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0269	0.0417	CbGbCtD
Maprotiline—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0258	0.04	CbGbCtD
Maprotiline—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0247	0.0383	CbGbCtD
Maprotiline—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0243	0.0377	CbGbCtD
Maprotiline—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0243	0.0377	CbGbCtD
Maprotiline—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0224	0.0346	CbGbCtD
Maprotiline—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0223	0.0345	CbGbCtD
Maprotiline—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0216	0.0335	CbGbCtD
Maprotiline—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.021	0.0325	CbGbCtD
Maprotiline—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0204	0.0316	CbGbCtD
Maprotiline—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0196	0.0303	CbGbCtD
Maprotiline—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0196	0.0303	CbGbCtD
Maprotiline—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.0188	0.029	CbGbCtD
Maprotiline—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0184	0.0285	CbGbCtD
Maprotiline—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0184	0.0285	CbGbCtD
Maprotiline—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.0145	0.0225	CbGbCtD
Maprotiline—ORM1—saliva—acquired immunodeficiency syndrome	0.00497	0.0767	CbGeAlD
Maprotiline—SLC6A3—nerve—acquired immunodeficiency syndrome	0.00266	0.0411	CbGeAlD
Maprotiline—SLC6A2—nerve—acquired immunodeficiency syndrome	0.00215	0.0331	CbGeAlD
Maprotiline—HTR7—nerve—acquired immunodeficiency syndrome	0.00207	0.0319	CbGeAlD
Maprotiline—DRD2—nerve—acquired immunodeficiency syndrome	0.00196	0.0302	CbGeAlD
Maprotiline—HTR7—endothelium—acquired immunodeficiency syndrome	0.00176	0.0272	CbGeAlD
Maprotiline—HTR7—blood plasma—acquired immunodeficiency syndrome	0.00156	0.0241	CbGeAlD
Maprotiline—CHRM5—skin of body—acquired immunodeficiency syndrome	0.00141	0.0218	CbGeAlD
Maprotiline—HTR2A—nerve—acquired immunodeficiency syndrome	0.00129	0.0199	CbGeAlD
Maprotiline—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00125	0.0193	CbGeAlD
Maprotiline—CHRM4—nervous system—acquired immunodeficiency syndrome	0.00112	0.0173	CbGeAlD
Maprotiline—HTR2A—endothelium—acquired immunodeficiency syndrome	0.0011	0.017	CbGeAlD
Maprotiline—CHRM4—central nervous system—acquired immunodeficiency syndrome	0.00108	0.0166	CbGeAlD
Maprotiline—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.000975	0.0151	CbGeAlD
Maprotiline—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000888	0.0137	CbGeAlD
Maprotiline—CHRM5—nervous system—acquired immunodeficiency syndrome	0.000874	0.0135	CbGeAlD
Maprotiline—CHRM4—brain—acquired immunodeficiency syndrome	0.000855	0.0132	CbGeAlD
Maprotiline—CHRM5—central nervous system—acquired immunodeficiency syndrome	0.000841	0.013	CbGeAlD
Maprotiline—DRD2—retina—acquired immunodeficiency syndrome	0.00081	0.0125	CbGeAlD
Maprotiline—ORM1—blood—acquired immunodeficiency syndrome	0.000792	0.0122	CbGeAlD
Maprotiline—ORM1—bone marrow—acquired immunodeficiency syndrome	0.000767	0.0118	CbGeAlD
Maprotiline—ORM1—spinal cord—acquired immunodeficiency syndrome	0.000763	0.0118	CbGeAlD
Maprotiline—SLC6A3—spinal cord—acquired immunodeficiency syndrome	0.00071	0.011	CbGeAlD
Maprotiline—ORM1—lung—acquired immunodeficiency syndrome	0.000695	0.0107	CbGeAlD
Maprotiline—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000686	0.0106	CbGeAlD
Maprotiline—CHRM5—brain—acquired immunodeficiency syndrome	0.000668	0.0103	CbGeAlD
Maprotiline—SLC6A3—lung—acquired immunodeficiency syndrome	0.000646	0.00997	CbGeAlD
Maprotiline—ORM1—nervous system—acquired immunodeficiency syndrome	0.000643	0.00993	CbGeAlD
Maprotiline—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000639	0.00987	CbGeAlD
Maprotiline—CHRM3—digestive system—acquired immunodeficiency syndrome	0.000632	0.00976	CbGeAlD
Maprotiline—ORM1—central nervous system—acquired immunodeficiency syndrome	0.000619	0.00956	CbGeAlD
Maprotiline—HTR7—digestive system—acquired immunodeficiency syndrome	0.000601	0.00929	CbGeAlD
Maprotiline—CHRM2—nervous system—acquired immunodeficiency syndrome	0.0006	0.00926	CbGeAlD
Maprotiline—SLC6A3—nervous system—acquired immunodeficiency syndrome	0.000598	0.00924	CbGeAlD
Maprotiline—CHRM1—lung—acquired immunodeficiency syndrome	0.00059	0.0091	CbGeAlD
Maprotiline—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000578	0.00893	CbGeAlD
Maprotiline—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.000578	0.00892	CbGeAlD
Maprotiline—SLC6A3—central nervous system—acquired immunodeficiency syndrome	0.000576	0.00889	CbGeAlD
Maprotiline—HTR7—blood—acquired immunodeficiency syndrome	0.000573	0.00885	CbGeAlD
Maprotiline—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000557	0.00859	CbGeAlD
Maprotiline—HTR7—spinal cord—acquired immunodeficiency syndrome	0.000552	0.00852	CbGeAlD
Maprotiline—CHRM1—nervous system—acquired immunodeficiency syndrome	0.000546	0.00843	CbGeAlD
Maprotiline—HTR2A—retina—acquired immunodeficiency syndrome	0.000534	0.00825	CbGeAlD
Maprotiline—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.000526	0.00812	CbGeAlD
Maprotiline—SLC6A2—lung—acquired immunodeficiency syndrome	0.000521	0.00805	CbGeAlD
Maprotiline—HTR7—lung—acquired immunodeficiency syndrome	0.000502	0.00775	CbGeAlD
Maprotiline—CHRM3—nervous system—acquired immunodeficiency syndrome	0.000489	0.00754	CbGeAlD
Maprotiline—SLC6A2—nervous system—acquired immunodeficiency syndrome	0.000483	0.00745	CbGeAlD
Maprotiline—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.00048	0.00741	CbGeAlD
Maprotiline—ORM1—lymph node—acquired immunodeficiency syndrome	0.000475	0.00734	CbGeAlD
Maprotiline—DRD2—lung—acquired immunodeficiency syndrome	0.000475	0.00733	CbGeAlD
Maprotiline—CHRM3—central nervous system—acquired immunodeficiency syndrome	0.00047	0.00726	CbGeAlD
Maprotiline—HTR7—nervous system—acquired immunodeficiency syndrome	0.000465	0.00718	CbGeAlD
Maprotiline—SLC6A2—central nervous system—acquired immunodeficiency syndrome	0.000465	0.00717	CbGeAlD
Maprotiline—CHRM2—brain—acquired immunodeficiency syndrome	0.000459	0.00708	CbGeAlD
Maprotiline—SLC6A3—brain—acquired immunodeficiency syndrome	0.000457	0.00706	CbGeAlD
Maprotiline—CYP1A2—blood—acquired immunodeficiency syndrome	0.000457	0.00706	CbGeAlD
Maprotiline—HRH1—digestive system—acquired immunodeficiency syndrome	0.000449	0.00693	CbGeAlD
Maprotiline—HTR7—central nervous system—acquired immunodeficiency syndrome	0.000448	0.00691	CbGeAlD
Maprotiline—HTR2C—brain—acquired immunodeficiency syndrome	0.000442	0.00682	CbGeAlD
Maprotiline—DRD2—nervous system—acquired immunodeficiency syndrome	0.00044	0.00679	CbGeAlD
Maprotiline—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000423	0.00654	CbGeAlD
Maprotiline—CHRM1—brain—acquired immunodeficiency syndrome	0.000417	0.00644	CbGeAlD
Maprotiline—CYP1A2—lung—acquired immunodeficiency syndrome	0.000401	0.00619	CbGeAlD
Maprotiline—HRH1—vagina—acquired immunodeficiency syndrome	0.000397	0.00612	CbGeAlD
Maprotiline—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000375	0.00579	CbGeAlD
Maprotiline—HRH1—lung—acquired immunodeficiency syndrome	0.000375	0.00579	CbGeAlD
Maprotiline—CHRM3—brain—acquired immunodeficiency syndrome	0.000373	0.00577	CbGeAlD
Maprotiline—SLC6A2—brain—acquired immunodeficiency syndrome	0.000369	0.0057	CbGeAlD
Maprotiline—HTR2A—blood—acquired immunodeficiency syndrome	0.000357	0.00552	CbGeAlD
Maprotiline—SLC6A2—lymph node—acquired immunodeficiency syndrome	0.000356	0.0055	CbGeAlD
Maprotiline—HTR7—brain—acquired immunodeficiency syndrome	0.000355	0.00549	CbGeAlD
Maprotiline—ABCB1—retina—acquired immunodeficiency syndrome	0.00035	0.0054	CbGeAlD
Maprotiline—HRH1—nervous system—acquired immunodeficiency syndrome	0.000347	0.00536	CbGeAlD
Maprotiline—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000344	0.00531	CbGeAlD
Maprotiline—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000342	0.00528	CbGeAlD
Maprotiline—DRD2—brain—acquired immunodeficiency syndrome	0.000336	0.00519	CbGeAlD
Maprotiline—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000334	0.00516	CbGeAlD
Maprotiline—HTR2A—vagina—acquired immunodeficiency syndrome	0.000331	0.00511	CbGeAlD
Maprotiline—CYP2D6—blood—acquired immunodeficiency syndrome	0.000325	0.00503	CbGeAlD
Maprotiline—HTR2A—lung—acquired immunodeficiency syndrome	0.000313	0.00484	CbGeAlD
Maprotiline—HTR2A—nervous system—acquired immunodeficiency syndrome	0.00029	0.00448	CbGeAlD
Maprotiline—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000279	0.00431	CbGeAlD
Maprotiline—HRH1—brain—acquired immunodeficiency syndrome	0.000265	0.0041	CbGeAlD
Maprotiline—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000264	0.00408	CbGeAlD
Maprotiline—HRH1—lymph node—acquired immunodeficiency syndrome	0.000256	0.00396	CbGeAlD
Maprotiline—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000254	0.00393	CbGeAlD
Maprotiline—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000249	0.00384	CbGeAlD
Maprotiline—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000246	0.00379	CbGeAlD
Maprotiline—ABCB1—blood—acquired immunodeficiency syndrome	0.000234	0.00361	CbGeAlD
Maprotiline—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000227	0.0035	CbGeAlD
Maprotiline—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000226	0.00348	CbGeAlD
Maprotiline—HTR2A—brain—acquired immunodeficiency syndrome	0.000222	0.00342	CbGeAlD
Maprotiline—ABCB1—vagina—acquired immunodeficiency syndrome	0.000217	0.00335	CbGeAlD
Maprotiline—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.000815	CcSEcCtD
Maprotiline—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.000814	CcSEcCtD
Maprotiline—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.000814	CcSEcCtD
Maprotiline—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000208	0.000813	CcSEcCtD
Maprotiline—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.000207	0.000812	CcSEcCtD
Maprotiline—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000207	0.000812	CcSEcCtD
Maprotiline—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.000207	0.000811	CcSEcCtD
Maprotiline—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000207	0.00081	CcSEcCtD
Maprotiline—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000207	0.00081	CcSEcCtD
Maprotiline—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000206	0.000807	CcSEcCtD
Maprotiline—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000206	0.000807	CcSEcCtD
Maprotiline—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000206	0.000805	CcSEcCtD
Maprotiline—ABCB1—lung—acquired immunodeficiency syndrome	0.000205	0.00317	CbGeAlD
Maprotiline—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000204	0.000801	CcSEcCtD
Maprotiline—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000204	0.0008	CcSEcCtD
Maprotiline—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000204	0.0008	CcSEcCtD
Maprotiline—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.000799	CcSEcCtD
Maprotiline—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000204	0.000799	CcSEcCtD
Maprotiline—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000204	0.000798	CcSEcCtD
Maprotiline—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.000795	CcSEcCtD
Maprotiline—Rash—Didanosine—acquired immunodeficiency syndrome	0.000203	0.000793	CcSEcCtD
Maprotiline—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000203	0.000793	CcSEcCtD
Maprotiline—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000203	0.000793	CcSEcCtD
Maprotiline—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000202	0.000793	CcSEcCtD
Maprotiline—CYP2D6—brain—acquired immunodeficiency syndrome	0.000202	0.00312	CbGeAlD
Maprotiline—Headache—Didanosine—acquired immunodeficiency syndrome	0.000201	0.000788	CcSEcCtD
Maprotiline—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000201	0.000786	CcSEcCtD
Maprotiline—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000201	0.000785	CcSEcCtD
Maprotiline—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000201	0.000785	CcSEcCtD
Maprotiline—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.0002	0.000784	CcSEcCtD
Maprotiline—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.0002	0.000784	CcSEcCtD
Maprotiline—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.0002	0.000783	CcSEcCtD
Maprotiline—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.0002	0.000782	CcSEcCtD
Maprotiline—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.000781	CcSEcCtD
Maprotiline—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.000781	CcSEcCtD
Maprotiline—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.000779	CcSEcCtD
Maprotiline—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.000779	CcSEcCtD
Maprotiline—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.000778	CcSEcCtD
Maprotiline—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000199	0.000777	CcSEcCtD
Maprotiline—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000198	0.000777	CcSEcCtD
Maprotiline—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000198	0.000775	CcSEcCtD
Maprotiline—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000198	0.000775	CcSEcCtD
Maprotiline—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000198	0.000774	CcSEcCtD
Maprotiline—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000197	0.000773	CcSEcCtD
Maprotiline—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000197	0.000772	CcSEcCtD
Maprotiline—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000197	0.000772	CcSEcCtD
Maprotiline—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.000767	CcSEcCtD
Maprotiline—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000195	0.000765	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.000765	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000195	0.000762	CcSEcCtD
Maprotiline—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000194	0.000761	CcSEcCtD
Maprotiline—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000194	0.000761	CcSEcCtD
Maprotiline—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000193	0.000755	CcSEcCtD
Maprotiline—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000193	0.000755	CcSEcCtD
Maprotiline—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000193	0.000754	CcSEcCtD
Maprotiline—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000193	0.000754	CcSEcCtD
Maprotiline—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.000753	CcSEcCtD
Maprotiline—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.000752	CcSEcCtD
Maprotiline—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000192	0.000751	CcSEcCtD
Maprotiline—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000192	0.000751	CcSEcCtD
Maprotiline—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000192	0.00075	CcSEcCtD
Maprotiline—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000191	0.000749	CcSEcCtD
Maprotiline—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000191	0.000748	CcSEcCtD
Maprotiline—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000191	0.000747	CcSEcCtD
Maprotiline—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000191	0.000746	CcSEcCtD
Maprotiline—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.000745	CcSEcCtD
Maprotiline—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.00019	0.000744	CcSEcCtD
Maprotiline—ABCB1—nervous system—acquired immunodeficiency syndrome	0.00019	0.00293	CbGeAlD
Maprotiline—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.000743	CcSEcCtD
Maprotiline—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000189	0.000742	CcSEcCtD
Maprotiline—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.000739	CcSEcCtD
Maprotiline—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000189	0.000738	CcSEcCtD
Maprotiline—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000188	0.000736	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000188	0.000736	CcSEcCtD
Maprotiline—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000188	0.000734	CcSEcCtD
Maprotiline—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000186	0.00073	CcSEcCtD
Maprotiline—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000186	0.000728	CcSEcCtD
Maprotiline—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.000726	CcSEcCtD
Maprotiline—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.000725	CcSEcCtD
Maprotiline—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000185	0.000725	CcSEcCtD
Maprotiline—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.000724	CcSEcCtD
Maprotiline—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.000723	CcSEcCtD
Maprotiline—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000185	0.000722	CcSEcCtD
Maprotiline—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000184	0.000722	CcSEcCtD
Maprotiline—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000184	0.000722	CcSEcCtD
Maprotiline—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.000721	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000184	0.00072	CcSEcCtD
Maprotiline—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.00072	CcSEcCtD
Maprotiline—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000184	0.000719	CcSEcCtD
Maprotiline—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000184	0.000719	CcSEcCtD
Maprotiline—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000183	0.000717	CcSEcCtD
Maprotiline—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000183	0.000717	CcSEcCtD
Maprotiline—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000183	0.000716	CcSEcCtD
Maprotiline—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000183	0.00283	CbGeAlD
Maprotiline—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000714	CcSEcCtD
Maprotiline—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000182	0.000714	CcSEcCtD
Maprotiline—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000182	0.000713	CcSEcCtD
Maprotiline—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000182	0.000713	CcSEcCtD
Maprotiline—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000182	0.000712	CcSEcCtD
Maprotiline—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.000711	CcSEcCtD
Maprotiline—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000181	0.00071	CcSEcCtD
Maprotiline—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000181	0.000709	CcSEcCtD
Maprotiline—Infection—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.000706	CcSEcCtD
Maprotiline—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.000705	CcSEcCtD
Maprotiline—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000179	0.000703	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.000702	CcSEcCtD
Maprotiline—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000179	0.000702	CcSEcCtD
Maprotiline—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000179	0.000699	CcSEcCtD
Maprotiline—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000178	0.000698	CcSEcCtD
Maprotiline—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000178	0.000698	CcSEcCtD
Maprotiline—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000697	CcSEcCtD
Maprotiline—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000178	0.000697	CcSEcCtD
Maprotiline—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000696	CcSEcCtD
Maprotiline—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000177	0.000695	CcSEcCtD
Maprotiline—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000692	CcSEcCtD
Maprotiline—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000176	0.000691	CcSEcCtD
Maprotiline—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000176	0.00069	CcSEcCtD
Maprotiline—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.00069	CcSEcCtD
Maprotiline—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.00069	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.000689	CcSEcCtD
Maprotiline—Rash—Stavudine—acquired immunodeficiency syndrome	0.000176	0.000689	CcSEcCtD
Maprotiline—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.000688	CcSEcCtD
Maprotiline—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000176	0.000688	CcSEcCtD
Maprotiline—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000176	0.000688	CcSEcCtD
Maprotiline—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000687	CcSEcCtD
Maprotiline—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000175	0.000687	CcSEcCtD
Maprotiline—Headache—Stavudine—acquired immunodeficiency syndrome	0.000175	0.000684	CcSEcCtD
Maprotiline—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000175	0.000684	CcSEcCtD
Maprotiline—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000175	0.000684	CcSEcCtD
Maprotiline—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000174	0.000683	CcSEcCtD
Maprotiline—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000174	0.000682	CcSEcCtD
Maprotiline—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000174	0.000681	CcSEcCtD
Maprotiline—Rash—Abacavir—acquired immunodeficiency syndrome	0.000173	0.000679	CcSEcCtD
Maprotiline—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000173	0.000678	CcSEcCtD
Maprotiline—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000678	CcSEcCtD
Maprotiline—Headache—Abacavir—acquired immunodeficiency syndrome	0.000172	0.000674	CcSEcCtD
Maprotiline—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000673	CcSEcCtD
Maprotiline—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000172	0.000672	CcSEcCtD
Maprotiline—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000172	0.000672	CcSEcCtD
Maprotiline—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.000668	CcSEcCtD
Maprotiline—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000667	CcSEcCtD
Maprotiline—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000665	CcSEcCtD
Maprotiline—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000664	CcSEcCtD
Maprotiline—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000664	CcSEcCtD
Maprotiline—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.000663	CcSEcCtD
Maprotiline—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000169	0.000663	CcSEcCtD
Maprotiline—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000168	0.00066	CcSEcCtD
Maprotiline—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000168	0.00066	CcSEcCtD
Maprotiline—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.000658	CcSEcCtD
Maprotiline—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000168	0.000658	CcSEcCtD
Maprotiline—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.000656	CcSEcCtD
Maprotiline—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000655	CcSEcCtD
Maprotiline—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000167	0.000653	CcSEcCtD
Maprotiline—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000166	0.000651	CcSEcCtD
Maprotiline—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.00065	CcSEcCtD
Maprotiline—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000166	0.00065	CcSEcCtD
Maprotiline—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000166	0.000649	CcSEcCtD
Maprotiline—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.000643	CcSEcCtD
Maprotiline—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000163	0.000639	CcSEcCtD
Maprotiline—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000163	0.000638	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000637	CcSEcCtD
Maprotiline—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000637	CcSEcCtD
Maprotiline—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000162	0.000634	CcSEcCtD
Maprotiline—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000162	0.000634	CcSEcCtD
Maprotiline—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000633	CcSEcCtD
Maprotiline—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.000632	CcSEcCtD
Maprotiline—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000161	0.000631	CcSEcCtD
Maprotiline—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000161	0.000631	CcSEcCtD
Maprotiline—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000161	0.000631	CcSEcCtD
Maprotiline—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.00016	0.000628	CcSEcCtD
Maprotiline—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000625	CcSEcCtD
Maprotiline—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00016	0.000625	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000613	CcSEcCtD
Maprotiline—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.000613	CcSEcCtD
Maprotiline—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000156	0.000613	CcSEcCtD
Maprotiline—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000609	CcSEcCtD
Maprotiline—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.000608	CcSEcCtD
Maprotiline—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000155	0.000608	CcSEcCtD
Maprotiline—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000154	0.000604	CcSEcCtD
Maprotiline—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000154	0.000604	CcSEcCtD
Maprotiline—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.000604	CcSEcCtD
Maprotiline—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000603	CcSEcCtD
Maprotiline—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000153	0.000599	CcSEcCtD
Maprotiline—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000153	0.000599	CcSEcCtD
Maprotiline—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000153	0.000598	CcSEcCtD
Maprotiline—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.000597	CcSEcCtD
Maprotiline—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000152	0.000595	CcSEcCtD
Maprotiline—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000151	0.00059	CcSEcCtD
Maprotiline—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.000586	CcSEcCtD
Maprotiline—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.000586	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000585	CcSEcCtD
Maprotiline—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.000584	CcSEcCtD
Maprotiline—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000149	0.000584	CcSEcCtD
Maprotiline—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.000584	CcSEcCtD
Maprotiline—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.000584	CcSEcCtD
Maprotiline—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.000581	CcSEcCtD
Maprotiline—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000148	0.00058	CcSEcCtD
Maprotiline—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000573	CcSEcCtD
Maprotiline—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000146	0.000571	CcSEcCtD
Maprotiline—ABCB1—brain—acquired immunodeficiency syndrome	0.000145	0.00224	CbGeAlD
Maprotiline—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000565	CcSEcCtD
Maprotiline—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000564	CcSEcCtD
Maprotiline—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000144	0.000564	CcSEcCtD
Maprotiline—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000562	CcSEcCtD
Maprotiline—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000562	CcSEcCtD
Maprotiline—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000143	0.000562	CcSEcCtD
Maprotiline—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000559	CcSEcCtD
Maprotiline—Rash—Indinavir—acquired immunodeficiency syndrome	0.000142	0.000557	CcSEcCtD
Maprotiline—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000142	0.000556	CcSEcCtD
Maprotiline—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000554	CcSEcCtD
Maprotiline—Headache—Indinavir—acquired immunodeficiency syndrome	0.000141	0.000553	CcSEcCtD
Maprotiline—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000141	0.000552	CcSEcCtD
Maprotiline—ABCB1—lymph node—acquired immunodeficiency syndrome	0.00014	0.00217	CbGeAlD
Maprotiline—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.000546	CcSEcCtD
Maprotiline—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000539	CcSEcCtD
Maprotiline—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000536	CcSEcCtD
Maprotiline—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000536	CcSEcCtD
Maprotiline—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000136	0.000531	CcSEcCtD
Maprotiline—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.00053	CcSEcCtD
Maprotiline—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000135	0.000528	CcSEcCtD
Maprotiline—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.000526	CcSEcCtD
Maprotiline—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.000526	CcSEcCtD
Maprotiline—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000134	0.000525	CcSEcCtD
Maprotiline—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.000523	CcSEcCtD
Maprotiline—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000522	CcSEcCtD
Maprotiline—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.00051	CcSEcCtD
Maprotiline—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00013	0.000508	CcSEcCtD
Maprotiline—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000505	CcSEcCtD
Maprotiline—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000503	CcSEcCtD
Maprotiline—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000128	0.000503	CcSEcCtD
Maprotiline—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000503	CcSEcCtD
Maprotiline—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000128	0.0005	CcSEcCtD
Maprotiline—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.000496	CcSEcCtD
Maprotiline—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000488	CcSEcCtD
Maprotiline—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000486	CcSEcCtD
Maprotiline—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000486	CcSEcCtD
Maprotiline—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.00048	CcSEcCtD
Maprotiline—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000121	0.000474	CcSEcCtD
Maprotiline—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.00047	CcSEcCtD
Maprotiline—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000469	CcSEcCtD
Maprotiline—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000465	CcSEcCtD
Maprotiline—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000465	CcSEcCtD
Maprotiline—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000464	CcSEcCtD
Maprotiline—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000462	CcSEcCtD
Maprotiline—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000452	CcSEcCtD
Maprotiline—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000114	0.000448	CcSEcCtD
Maprotiline—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000448	CcSEcCtD
Maprotiline—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000448	CcSEcCtD
Maprotiline—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000445	CcSEcCtD
Maprotiline—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000439	CcSEcCtD
Maprotiline—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000431	CcSEcCtD
Maprotiline—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000427	CcSEcCtD
Maprotiline—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000427	CcSEcCtD
Maprotiline—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000425	CcSEcCtD
Maprotiline—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000422	CcSEcCtD
Maprotiline—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000403	CcSEcCtD
Maprotiline—CHRM3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.78e-05	0.000821	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.78e-05	0.000821	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.78e-05	0.000821	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.77e-05	0.000818	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	2.75e-05	0.000813	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.74e-05	0.000811	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.74e-05	0.000811	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	2.74e-05	0.00081	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.72e-05	0.000805	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.72e-05	0.000805	CbGpPWpGaD
Maprotiline—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.71e-05	0.0008	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.68e-05	0.000792	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.68e-05	0.000792	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.67e-05	0.000791	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.67e-05	0.000791	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.67e-05	0.000791	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.67e-05	0.000788	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.67e-05	0.000788	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.67e-05	0.000788	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.67e-05	0.000788	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.66e-05	0.000785	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.66e-05	0.000785	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.65e-05	0.000784	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.63e-05	0.000779	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	2.63e-05	0.000778	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	2.63e-05	0.000778	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.62e-05	0.000776	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.62e-05	0.000776	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.62e-05	0.000774	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.62e-05	0.000774	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.61e-05	0.000772	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.61e-05	0.000772	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.6e-05	0.000769	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.6e-05	0.000769	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.59e-05	0.000765	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	2.58e-05	0.000762	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	2.58e-05	0.000762	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.58e-05	0.000761	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.56e-05	0.000757	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.55e-05	0.000754	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.54e-05	0.000751	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.53e-05	0.000749	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.53e-05	0.000748	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.52e-05	0.000746	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.52e-05	0.000746	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.52e-05	0.000745	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.51e-05	0.000743	CbGpPWpGaD
Maprotiline—SLC6A2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.51e-05	0.000741	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	2.49e-05	0.000736	CbGpPWpGaD
Maprotiline—HTR2A—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	2.48e-05	0.000732	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.46e-05	0.000728	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.44e-05	0.000722	CbGpPWpGaD
Maprotiline—CHRM2—SIDS Susceptibility Pathways—IL6—acquired immunodeficiency syndrome	2.43e-05	0.000719	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.42e-05	0.000716	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.42e-05	0.000716	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.42e-05	0.000716	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.42e-05	0.000715	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.41e-05	0.000713	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.41e-05	0.000712	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.4e-05	0.00071	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.38e-05	0.000704	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.38e-05	0.000704	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	2.38e-05	0.000703	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.38e-05	0.000703	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.38e-05	0.000703	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	2.38e-05	0.000703	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.37e-05	0.000701	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.37e-05	0.000701	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	2.37e-05	0.0007	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.36e-05	0.000698	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.36e-05	0.000698	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.34e-05	0.000692	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.34e-05	0.000692	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.34e-05	0.000691	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.34e-05	0.000691	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.31e-05	0.000682	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.3e-05	0.00068	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.26e-05	0.000669	CbGpPWpGaD
Maprotiline—SLC6A3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.22e-05	0.000657	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.21e-05	0.000653	CbGpPWpGaD
Maprotiline—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.21e-05	0.000653	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.2e-05	0.00065	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.2e-05	0.00065	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.12e-05	0.000625	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.09e-05	0.000617	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.08e-05	0.000614	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.08e-05	0.000614	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.07e-05	0.000612	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.06e-05	0.000608	CbGpPWpGaD
Maprotiline—DRD2—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.06e-05	0.000608	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.03e-05	0.0006	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.01e-05	0.000595	CbGpPWpGaD
Maprotiline—CHRM1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.01e-05	0.000595	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2e-05	0.000591	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2e-05	0.00059	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.99e-05	0.000589	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.99e-05	0.000588	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.99e-05	0.000588	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.99e-05	0.000587	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.98e-05	0.000585	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.97e-05	0.000581	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.96e-05	0.00058	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	1.96e-05	0.000579	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.96e-05	0.000578	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.95e-05	0.000576	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	1.93e-05	0.000571	CbGpPWpGaD
Maprotiline—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.92e-05	0.000567	CbGpPWpGaD
Maprotiline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.91e-05	0.000565	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.91e-05	0.000564	CbGpPWpGaD
Maprotiline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.91e-05	0.000564	CbGpPWpGaD
Maprotiline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	1.9e-05	0.000562	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.88e-05	0.000556	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.84e-05	0.000545	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.83e-05	0.00054	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.82e-05	0.000537	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.81e-05	0.000536	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.81e-05	0.000535	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.8e-05	0.000533	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.8e-05	0.000532	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.8e-05	0.000531	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.79e-05	0.000531	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.79e-05	0.000529	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.79e-05	0.000528	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.78e-05	0.000527	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.78e-05	0.000527	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.78e-05	0.000526	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.78e-05	0.000525	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.77e-05	0.000523	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.77e-05	0.000522	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.75e-05	0.000518	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.72e-05	0.00051	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.68e-05	0.000497	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.67e-05	0.000495	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.66e-05	0.000491	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.66e-05	0.000489	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.65e-05	0.000488	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.65e-05	0.000487	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.65e-05	0.000487	CbGpPWpGaD
Maprotiline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.64e-05	0.000486	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.64e-05	0.000485	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.63e-05	0.000483	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.63e-05	0.000482	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.63e-05	0.000481	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.62e-05	0.00048	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.62e-05	0.00048	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.62e-05	0.000479	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.62e-05	0.000479	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.62e-05	0.000479	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.6e-05	0.000474	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.58e-05	0.000467	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.56e-05	0.00046	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.53e-05	0.000453	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.52e-05	0.00045	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.51e-05	0.000447	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.51e-05	0.000446	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.5e-05	0.000443	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.49e-05	0.000442	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.49e-05	0.000441	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.49e-05	0.00044	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.48e-05	0.000439	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.47e-05	0.000436	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.47e-05	0.000435	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.47e-05	0.000434	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.43e-05	0.000423	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.43e-05	0.000423	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.42e-05	0.000421	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.41e-05	0.000416	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.41e-05	0.000416	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.4e-05	0.000415	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.4e-05	0.000415	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.4e-05	0.000414	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.4e-05	0.000414	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.4e-05	0.000413	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.4e-05	0.000413	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.39e-05	0.000412	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.38e-05	0.000409	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.38e-05	0.000409	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.36e-05	0.000403	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.33e-05	0.000394	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.23e-05	0.000365	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.21e-05	0.000359	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.2e-05	0.000354	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.11e-05	0.000328	CbGpPWpGaD
Maprotiline—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.1e-05	0.000326	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.09e-05	0.000322	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.09e-05	0.000321	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.07e-05	0.000317	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.07e-05	0.000317	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.07e-05	0.000316	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.07e-05	0.000315	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.06e-05	0.000314	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.06e-05	0.000312	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.06e-05	0.000312	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.05e-05	0.000311	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.05e-05	0.000311	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.05e-05	0.00031	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.05e-05	0.000309	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.04e-05	0.000307	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.04e-05	0.000307	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.04e-05	0.000306	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.03e-05	0.000306	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.03e-05	0.000305	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.02e-05	0.000302	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.81e-06	0.00029	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.65e-06	0.000285	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.63e-06	0.000285	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.6e-06	0.000284	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.59e-06	0.000284	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.57e-06	0.000283	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.47e-06	0.00028	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.44e-06	0.000279	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.42e-06	0.000278	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.39e-06	0.000277	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.36e-06	0.000277	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.27e-06	0.000274	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.27e-06	0.000274	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.71e-06	0.000257	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.67e-06	0.000256	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.22e-06	0.000243	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.18e-06	0.000242	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—ALB—acquired immunodeficiency syndrome	8.15e-06	0.000241	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.88e-06	0.000233	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.84e-06	0.000232	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.42e-06	0.00019	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.39e-06	0.000189	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.67e-06	0.000167	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.64e-06	0.000167	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.58e-06	0.000165	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.56e-06	0.000164	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.55e-06	0.000164	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.55e-06	0.000164	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.54e-06	0.000164	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.53e-06	0.000163	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.52e-06	0.000163	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.5e-06	0.000163	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.47e-06	0.000162	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.45e-06	0.000161	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	5.17e-06	0.000153	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.12e-06	0.000151	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	4.87e-06	0.000144	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.83e-06	0.000143	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.63e-06	0.000137	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	4.13e-06	0.000122	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.77e-06	0.000112	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.33e-06	9.84e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.28e-06	9.69e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.27e-06	9.67e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.26e-06	9.63e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.25e-06	9.6e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.22e-06	9.51e-05	CbGpPWpGaD
